IMV Inc. to Announce First Quarter 2021 Results and Host a Conference Call and Webcast on May 12, 2021

Author's Avatar
Apr 29, 2021

IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines to fight against infectious diseases, announced today that it will hold a conference call and webcast on Wednesday, May 12, 2021 at 8:00 a.m. ET to discuss the company’s first quarter 2021 financial and operational results.